The database network taking it to the next level..... Bodo Grimbacher, MD University of Freiburg, Germany Head of ESID patient registries.

Slides:



Advertisements
Similar presentations
The Place of Multiple Sclerosis in the European Union Policy – the example of EMSPs MS Barometer 2008 Christoph Thalheim Secretary General, European MS.
Advertisements

Introduction Parkinsons disease is not just a burden for the patients it also has a substantial social and economic impact. The European countries differ.
The Public Finance and Empoyment Database of the OECD Dirk Kraan National Accounts Working Party Paris 1 December 2010.
Health in Prisons Project Establishing a Monitoring Mechanism on Prison Health Indicators and Health Determinants Working Party on Information on Lifestyle.
The European Law Students Association Albania ˙ Austria ˙ Azerbaijan ˙ Belgium ˙ Bosnia and Herzegovina ˙ Bulgaria ˙ Croatia ˙ Cyprus ˙ Czech Republic.
UNIVERSITY OF JYVÄSKYLÄ INTERNATIONAL COOPERATION.
Folke Sjöqvist and Michael Orme 1 Questionnaire on Clinical Pharmacology.
Current status of the recognition of the clinical / medical genetics specialty Milan Macek Department of Biology and Medical Genetics Charles University.
Tervisepank ® e-solution for primary care Madis Tiik, MD CEO, Estonian Society of Family Doctors
FACULTY OF BUSINESS AND ECONOMIC SCIENCES FINLAND – JOENSUU MEP 2013.
Delegations III KAM, Bratislava 4th to 8th September 2013.
Study Visits IV KAM Prague, 3 rd to 7 th September 2014.
Knowledge Management LXV International Council Meeting Qawra, Malta 16 th - 23 rd of March 2014.
Study Visits ICM Croatia, Opatija, 27th October to 3th November 2013.
SERVICES TRADE RESTRICTIVENESS INDEX PROFESSIONAL SERVICES ARCHITECTURE Russell V. Keune Architect, USA.
Institutional Visits IV KAM Prague, 3 rd to 7th September.
Delegations IV KAM Prague 3rd to 7th September 2014.
Institutional Visits ICM Cluj Napoca, 19 th to 26 th April 2015 Patrick Zischeck, Assistant for IV and SV.
1 EUROPA DONNA – The European Breast Cancer Coalition Susan Knox, Executive Director KEEPING BREAST CANCER ON THE EUROPEAN HEALTH AGENDA.
ELSA Shop(ping) LXIV International Council Meeting Opatija, Croatia October 28 th - November 3 rd 2013.
Adoption and take up of standards and profiles for e-Health Interoperability Jos Devlies, EuroRec, Belgium based on a presentation by Ib Johanson, MedCom,
Institutional Visits III KAM, Bratislava 4th to 8th September 2013.
Health Promotion Networks. Copenhagen, Denmark. 16 October The Health in Prisons Programme HIPP – WHO/Europe’s Network on Prison & Health Stefan.
Study Visits LXV International Council Meeting Qawra, Malta 16 th - 23 rd of March 2014.
Area Definition III KAM,Bratislava. The European Law Students’ Association Albania ˙ Austria ˙ Azerbaijan ˙ Belgium ˙ Bosnia and Herzegovina ˙ Bulgaria.
OECD Review of Russian Statistics Peer Review Mission to Russia April 2012 Tim Davis Head, Global Relations, Statistics Directorate.
Progress report of the ESID online registry Bodo Grimbacher, MD Head of ESID patient registries
ELSA Law Schools ICM Cluj-Napoca, 21st April 2015.
Affordable Healthcare IT Solutions. MU RX Compliance with Meaningful Use Stage 2.
Role of the Oncology Research Team Carmen B. Jacobs, BS, RN,OCN, CCRP U.T.M.D. Anderson Cancer Center Houston, Texas U.S.A.
Grants LXIV International Council Meeting 19th – 26th October, Bodrum Turkey.
The Research Council of Norway's international strategy Kristin Danielsen Director.
Make it Smart&Creative ICM Cluj-Napoca, 21st April 2015.
Study Visits ICM Cluj Napoca, 19 th to 26 th April 2015 Patrick Zischeck, Assistant for IV and SV.
Prof. Giuseppe Burgio, EuroSapienza, Rome. My presentation: 1.From the end of the 2nd World War to the European UnionFrom the end of the 2nd World War.
Institutional Visit LXV International Council Meeting Qawra, Malta 16 th - 23 rd of March 2014.
ELSA as the Franchise? LXV International Council Meeting Qawra, Malta 16 th - 23 rd of March 2014.
EXTREME MAKEOVER Members’ Magazine LXIV International Council Meeting Opatija, Croatia October 28 th - November 3 rd 2013.
Map - Region 3 Europe.
ELSA Summer Law Schools IV KAM Prague, 3rd to 7th September 2014.
© Enterprise Europe Network South West 2009 The Eurostars Programme Kenny Legg R&D Funding for the Environmental Sector – 29 June 2010 European Commission.
Which role is yours? ADV and Promotion of ELSA projects/events LXIV International Council Meeting Opatija, Croatia October 28 th - November 3 rd 2013.
European Union. Refresher  Market: the interaction of buyers and sellers exchanging goods and services  Trade: the process of buying, selling, or exchanging.
The ESID Online Registry Current figures and perspectives Benjamin Gathmann, ESID Online Database manager Division of Rheumatology and Clinical Immunology.
Promotion of AA Projects 2015/2016 ICM Batumi 18 th -25 th October 2015.
THE EUROPEAN UNION.
E u r o g u i d a n c e A Network of National Resource and Information Centres for Guidance Established in 1992.
The Schengen Agreement And its implications on tourism.
The 19 th of June 1990 : The Schengen Implementing Convention has been signed by : - Germany - Belgium - France - Luxembourg - Netherlands Calendar.
Comparing Britain with other nations: problems of measuring if and how we differ Roger Jowell, City University Director, European Social Survey Gresham.
The European Law Students’ Association Albania ˙ Austria ˙ Azerbaijan ˙ Belgium ˙ Bosnia and Herzegovina ˙ Bulgaria ˙ Croatia ˙ Cyprus ˙ Czech Republic.
Reformation of Toastmasters Districts in Continental Europe Prepared by Morag Mathieson DTM Committee Chair Presented to DECMs of D59 & D95 on February.
International Student´s permits Police Department of Central Finland.
Chief Financial Officers List
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 2– Freedom Movement for Workers Bilateral.
The Role of the Rectors’ Conferences in Europe Henriette Stöber Central European University & University of York Erasmus Mundus MAPP - Master of Public.
Table 1. Number and rate of reported confirmed syphilis cases per population by country and year, EU/EEA, 2010–2014 ASR: age-standardised rate,
Table 1. Number and rate of Legionnaires’ disease cases per population by country and year, EU/EEA, 2010–2014 ASR: age-standardised rate, C: case-based.
Best Sustainable Development Practices for Food Security UV-B radiation: A Specific Regulator of Plant Growth and Food Quality in a Changing Climate The.
BOLOGNA SYSTEM. BOLOGNA DECLARATION Signed by the Ministers of Education of 29 European countries, including Polish and Italian on the 19th of June 1999.
DISTRIBUTION AUTOMATIC - GENERATION
Anti-IgA antibodies: Risks and safety of immunoglobulin substitution
802.11b Wireless Access Point
UN legal instruments relevant for Inland Water Transport
Table 1. Number and rate of reported confirmed syphilis cases per 100 000 population by country and year, EU/EEA, 2010–2014 Country
Support to National Helpdesks
EUROPEAN PERIOPERATIVE Safe Surgery Saves Lives
"Financing Natura 2000 Guidance and Workshops”
Regional Accounts ESA 95 Data Collection
Collecting methodological information on regional statistics
Presentation transcript:

The database network taking it to the next level..... Bodo Grimbacher, MD University of Freiburg, Germany Head of ESID patient registries

Registry The existing ESID Registry Up-to-date patient- and research-databases The ESID Main Patient Registry The CVID Subregistry Requirements Time schedule Support for the documenting centers Summary Prospectives

a non-profit organization established in 1983, became a society in 1994 to facilitate the exchange of ideas and information among doctors, nurses, biomedical studies, patients and their families, collaboration with IPOPI and INGID to establish common diagnostic criteria (together with PAGID) (Clin. Immunol. 1999; 93:190). to promote research on causes, mechanisms and treatment - summer schools (education, pathogenesis, treatment of primary immunodeficiencies) - biennual scientific meetings (next: October, 2004 in Versailles, France) All ESID Countries Austria Belgium Croatia Czech- Republic Denmark Estonia Finland France Germany Greece Hungary Iceland Ireland Israel Italy Netherlands Norway Poland Portugal Russia Serbia- Montenegro Spain Sweden Switzerland Turkey United- Kingdom President: Prof. L. D. Notarangelo, Brescia, Italy; Secretary: Prof. H. Wolf, Vienna, Austria Main patient registry 10,717 recorded cases of Primary Immunodeficiencies in Europe

Registry The existing ESID Registry Up-to-date patient- and research-databases The ESID Main Patient Registry The CVID Subregistry Requirements Time schedule Support for the documenting centers Summary Prospectives

What features should a patient- and research database have? m Longitudinal Analysis of a single patient and a cohort of patients m Cross-sectional Analysis of patient cohorts m Multivariate Analysis and complex database queries m Variable programming of queries m Easy implementation of new databases via XML-programming m Data-entry via electronic Import, Scanning-Function or manually m Connecting medical centers world-wide m Accessable any time from any place m Patient-Report-Generation m Recall-Function m Security: Implementation of rules for patient‘s data protection m Access: controlled by complex User-Role-Management

Concept and architecture of an internet based ESID database network User-Role management User-Password: Handles access to the ESID-database system

XML View ModelController DBJava2EnterpriseEdition Server XML Initialisierung Client access via Standard Internet Browser Server Client Thin Client-Server Architecture OperatingSystem: Unix

3. Additional Subregistries on demand ESID Main Patient Registry CVID Subregistry DGS Subregistry NBS Subregistry XLA Subregistry HIGM Subregistry SCID Subregistry Neutropenia Subregistry... Additional Subregistries ESID Main Registry & Subregistries 2. CVID Subregistry 1. ESID Main Registry

The existing ESID Registry Up-to-date patient- and research-databases The ESID Main Patient Registry The CVID Subregistry Requirements Time schedule Support for the documenting centers Summary Prospectives

Core data-subset PATIENT: Sex, date of birth, region of residence (clustered in regions with > 30 millions inhabitants) DIAGNOSIS: Date of diagnosis, onset of symptoms, disease/diagnosis THERAPY: Date, drug, dose per weight, dose interval, route (oral / SC / IV), from, until, side-effects, reason stopped, compliance PHARMACO-ECON: Days in hospital, days missed at school, days missed at work IMMUNIZATIONS: Date, vaccine, postvaccinal titres LABORATORY: Date, time, label, value (IgG, IgA, IgM, CD3, CD4, CD8, CD19 or CD20, CD56, Leukocytes, Thrombocytes, Erythrocytes, Lymphocytes, Granulocytes, Hb, Eosinophils, Basophils, Macrophages) in percent or/and in absolute values

The ESID Main Registry

The ESID Main Registry

The ESID Main Registry

The ESID Main Registry

The existing ESID Registry Up-to-date patient- and research-databases The ESID Main Patient Registry The CVID Subregistry Requirements Time schedule Support for the documenting centers Summary Prospectives

Datamodel: CVID database-system

The CVID Subregistry

The CVID Subregistry

The CVID Subregistry

The CVID Subregistry

The CVID Subregistry

The CVID Subregistry

The CVID Subregistry

The CVID Subregistry

The CVID Subregistry

The CVID Subregistry

The CVID Subregistry

Registry The existing ESID Registry Up-to-date patient- and research-databases The ESID Main Patient Registry The CVID Subregistry Requirements Time schedule Support for the documenting centers Summary Prospectives

 Positive statement of data protection officer and/or ethics board  Signed consent form from patients  Database models Requirements

Data protection approval: source document

Ethics vote: source document

 Positive statement of data protection officer and/or ethics board  Signed consent form from patients  Database models Requirements

Consent form for patients

 Positive statement of data protection officer and/or ethics board  Signed consent form from patients  Database models Requirements

PID Classification & Steering committees

Registry The existing ESID Registry Up-to-date patient- and research-databases The ESID Main Patient Registry The CVID Subregistry Requirements Time schedule Support for the documenting centers Summary Prospectives

Time schedule Sept. 1st 2003Start of project Jan. 27th, 2004CVID-datamodel submitted Jan. 29th, 2004NBS-datamodel submitted Feb. 2nd, 2004DGS-datamodel submitted Feb. 19th, 2004osteopetrosis-datamodel submitted March 8th, 2004The beta-version goes online May 15th, 2004End of test drive June 15th, 2004The ESID-registry will go online with the ESID-main-registry and the CVID subregistry October 1st, 2004additional 3 subregistries implemented from there on:additional 4 subregistries per year

Registry The existing ESID Registry Up-to-date patient- and research-databases The ESID Main Patient Registry The CVID Subregistry Requirements Time schedule Support for the documenting centers Summary Prospectives

The ESID registry working party has made major steps towards an ”ESID Online Patient- and Research-Registry”. We are about to develop a multi-centred data collection system in European and Non-European countries for patients with Primary Immunodeficiencies. The data collected in the participating centres shall be pseudonymized and thereafter be entered and made accessible in a central online registry. The registry will consist of multiple 'disease-specific subregistries'. Data from e.g. national registries will be automatically transferrable to eliminate the need of a second registration. The system will enable the user to enter any data at any time for any visit. We are asking for yearly updates of the records. With PPTA (Plasma Protein Therapeutics Association), the major financial sponsor of this project, we are about to arrange a financial compensation for the use of secretarial help for the documentation. For this project, ESID is asking for support from all physicians and researchers involved in the diagnosis, care, treatment, and support of patients with PID. The bonus system is set up as follows:  ESID suggests to compensate for secretarial assistence with 5 € per documented patient for whom a core dataset (red fields) has been documented and 10 € for each documented patient for whom an extended dataset (blue fields) has been documented.  In addition, there shall be an annual award for the five best publications of the five disciplines (Antibody deficiencies, T-cell or combined deficiencies, Phagozytic disorders, Complement disorders, Other PIDs) within PID using data of the ESID registry of about EUR 2.000,00 per publication and an extra award of EUR 5.000,00 for the best publication over all.  Furthermore, a center which has reached a specific number of documented patients shall be rewarded by travel grants to either the ESID summer school or the biannual ESID scientific meetings. Free registration to the meetings is also beeing discussed.  Each center may install the database locally to be able to work with personalized data, since the application will be able to generate patient reports to be sent e.g. to the home-physician. In addition, the database will support features like 'recall functions' which will remember the physician if a patient has not shown up for his/her regular follow-up visit. There will be a patient consent to be signed to ensure that the patient supports the initiative. It will be the centers' responsibility to obtain the patient consent. However, all PID patient organizations so far supported this project since it is designed to increase awareness and diagnosis of PID and to facilitate research in the field. We are prepared to provide you with all documents you will need for patients consents and ethics approvals. Thank you for your collaboration! By now about 150 confirmations of intended colla- boration by single documentation centers Letter to the ESID members Bonus system:  Compensation for secretarial assistance (EUR 10 per patient per year)  Annual award for the best publications within PID using data of the ESID Registry  Travel grants to ESID meetings and summer school  Possibility to work with personalized data plus recall-functions

Registry The existing ESID Registry Up-to-date patient- and research-databases The ESID Main Patient Registry The CVID Subregistry Requirements Time schedule Support for the documenting centers Summary Prospectives

Industry access to a core dataset additional data for post licensing surveillance data for marketing advertisement, publicity close contact to a world- wide network of high- profile research institutions Patients optimize research implement standards for diagnosis and therapy improve quality of life meet the patient‘s needs support the spirit of ESID Physicians research across centers using a huge database enable genetic, and therapeutic trials within ESID secretarial assisitance automated patient reports Why support the ESID-online registry?

Registry The existing ESID Registry Up-to-date patient- and research-databases The ESID Main Patient Registry The CVID Subregistry Requirements Time schedule Support for the documenting centers Summary Prospectives for participating countries

Decision 1: Do I need a signed consent form for the registry in my country? Do I need a vote from my ethical review board? Decision 2: Do I wish to have a personalized version of the ESID registry as a national registry, running behind the the firewall of my university? Question 1: What do I need from ESID to facilitate the registration of my patients? Does my center have the technical requirements for runnig the ESID database? Question 2: Can I improve the ESID registry? Prospectives

The online patient and research database network Bodo Grimbacher MD; Dominic Veit MA; Barbara Frisch MA University of Freiburg, Germany ESID patient registries

Concept and architecture of an internet based ESID database network Security and Dataprotection Input requires a positive statement from the local data protection officer and a signed consent from the patient(s) or legal tutor (approved form provided in 6 languages) SSL encrypted data transmission Secure Server Net (audited Firewall of the Hospital of Freiburg) User-Role Authentication Passwords are stored in encrypted form Multiple-User-Roles restrict views and presented data Patient randomization (patient ID’s) Only coded data allowed (ONLY the patient’s physician can match a specific data-set with his patients) No demographical data or ‘free text’ that potentially directly identifies the patient is stored in the system Meet the standards set by FDA CFR 21 Part 11 for Good Clinical Practice and ISO 9001 for Quality Control

Concept and architecture of an internet based ESID database network The network structure ESID registry: Disease-specific subregistries A b Local patient registry a B... National patient registries Centers AIEOP CINECA Italy National DB Local physicians Hospitals/INGID ESID mutation databases IPOPI

Existing registries/databases in: Italy 04/03 Spain 09/03 Poland 10/03 Czech 11/03 Paris 12/03 Hannover 02/04 Munich 03/04 Ulm Belgium Hungary The Netherlands Portugal Sweden...